Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Levered Free Cash Flow (FCF)

Rigel Pharmaceuticals Levered Free Cash Flow (FCF) Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-6m a -60.67% increase of 4m year over year
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-13m a -128.01% increase of 17m year over year
  • Rigel Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2019 was $-24m a -46.41% increase of 11m from 2018
  • Rigel Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2018 was $-36m a -34.69% increase of 12m from 2017
  • Rigel Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2017 was $-48m a 12.59% decrease of -6m from 2016
Other Cash Flow Metrics:
  • Rigel Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $12m a 300.91% increase of 35m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Levered Free Cash Flow (FCF) Data

06/2020$-6m
03/2020$-12m
12/2019$15m
09/2019$-10m
06/2019$-9m
03/2019$-20m
12/2018$9m
09/2018$-11m
06/2018$-19m
03/2018$-14m

Annual RIGL Levered Free Cash Flow (FCF) Data

2019$-24m
2018$-36m
2017$-48m
2016$-42m
2015$0m
2014$-41m
2013$-52m
2012$-51m
2011$-40m
2010$30m